MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Post-Election Commentary—C.R. Bard

C.R. BardC.R. Bard Timothy Ring, chairman and CEO, speaking during the Stifel 2016 Healthcare Conference on November 15:


"I would suggest that changes in the Affordable Care Act or repeal isn't going to have that much of an impact on the volume. It didn't have the impact coming in with the incremental volume. We haven't had the price increase we'd pass on from the device tax. I wouldn't see a big change in terms of volumes going out either . . . 

Maybe our hospital customer base is maybe a little bit healthier. They didn't take that incremental income and go buy more medical devices. If you look at medical device expenditure as a percentage of all healthcare costs, it stayed about the same. 

So, for the device industry, and my comments are specifically related to that, I wouldn't see frankly much of a change . . ."

On the device tax:

"I don't know if it would have come back regardless of the election outcome. I think it would have been in a state of continued suspension on a going-forward basis as opposed to an outright repeal. Given the outcome we've seen . . . the outright repeal is probably more likely . . .

I think the probability goes up that that goes away permanently, but it's been suspended anyway. So there won't be anything incremental, other than the cloud removed over everybody's head."


[Image courtesy of C.R. Bard]

Take the Medical Innovation Tours during the BIOMEDevice San Jose Conference and Expo, December 7-8.
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.